-
JP Morgan Maintains Neutral Rating On Biogen Idec After Positive Phase 3 BG-12 Results
Monday, April 11, 2011 - 9:22amJP Morgan has published a research report on Biogen Idec (NASDAQ: BIIB) after the company announced positive results for its phase 3 DEFINE trial of BG-12 in RRMS. In the report, JP Morgan writes, "Against placebo, both doses of BG-12 (240mg BID and TID) meet the primary endpoint of annual relapse...
Read More >> -
Biogen Announced Positive Phase 3 Results For BG-12, Deutsche Bank Maintains Hold
Monday, April 11, 2011 - 9:15amDeutsche Bank has published a research report on Biogen Idec Inc. (NASDAQ: BIIB) after the company announced positive top-line results for the BG-12 phase 3 trial this morning. In the report, Deutsche Bank writes "Biogen will likely try to publish DEFINE results at an upcoming medical meeting in...
Read More >> -
Icahn Moves To Sell Biogen Idec (BIIB) After Adding another Director
Monday, March 22, 2010 - 6:03pmBillionaire activist investor Carl Icahn announced that he will attempt to sell Biogen Idec Inc (Nasdaq: BIIB). Icahn Partners LP and its affiliates own 16.1 million shares, or 6% of outstanding shares, of Biogen Idec. Icahn has had a series of proxy battles with Biogen Idec and the company...
Read More >> -
Roche And Biogen Idec (BIIB) Suspend Rheumatoid Arthritis Drug Program
Monday, March 8, 2010 - 9:07amSwiss pharmaceutical company Roche Holding AG and Biogen Idec Inc (Nasdaq: BIIB) announced on Monday that safety concerns had caused them to suspend a program to treat rheumatoid arthritis with drug candidate ocrelizumab. The independent Data and Safety Monitoring Board had found that the potential...
Read More >> -
Biogen Idec Inc (Nasdaq: BIIB) Posts Strong Earnings Growth
Tuesday, February 9, 2010 - 10:42amBiotech company Biogen Idec Inc (Nasdaq: BIIB) reported a rise in 4th quarter earnings and revenue. Biogen Idec Inc said that it earned $306 million, or $1.06 per share, compared with $207 million, or 70 cents per share, for the same quarter a year earlier. Revenue for the 4th quarter was up 5% to...
Read More >>
Biogen Idec Inc
From Benzinga's Newsdesk
- 07:46 AM Costco Wholesale May Comparable Store Sales up 4%
- 07:42 AM From Earlier: WuXi PharmaTech Receives GLP Statement for Suzhou Toxicology Facility
- 07:41 AM PVI Holdings And Sun Life Financial Sign An Agreement To Form A Life Insurance Joint Venture
- 07:38 AM President and CEO of Weingarten Realty is Scheduled to Appear on CNBC's Street Signs Today
- 7:36 AM UPDATE: May Challenger Job Cuts 61.9K vs 40.6K Prior
- 07:35 AM NV Energy Announces Appointments of New CFO and COO
- 07:34 AM UPDATE: Wunderlich Securities Upgrades Ubiquiti Networks to Buy on Valuation
- 07:34 AM Brean Murray Carret Reiterates Buy, $20 PT on Pitney Bowes on Cash Flow Confidence
- 07:34 AM Financial Breakfast: Morning News Summary for May 31, 2012
- 07:34 AM UPDATE: DA Davidson Raises PT to $45 on Texas Capital Bancshares on Higher Mortgage Revenues
- 07:33 AM From Earlier: Velti Announces Purchase of Shares by Non-Executive Directors and Senior Employees
- 07:32 AM The Bon-Ton Stores, Inc. Announces May Sales +1.5%
- 07:31 AM Patagonia Signs Multiyear Renewal Agreement With Alliance Data's Epsilon For Database Marketing Services
- 07:31 AM Chelsea Therapeutics Reports Top-Line Results of Phase II Trial of CH-4051 in Rheumatoid Arthritis
- 07:31 AM UPDATE: Pivotal Research Group Upgrades Facebook to Hold
Brain Trust
- Costco Wholesale May Comparable Store Sales up 4%
- From Earlier: WuXi PharmaTech Receives GLP Statement for Suzhou Toxicology Facility
- PVI Holdings And Sun Life Financial Sign An Agreement To Form A Life Insurance Joint Venture
- President and CEO of Weingarten Realty is Scheduled to Appear on CNBC's Street Signs Today
- NV Energy Announces Appointments of New CFO and COO
- UPDATE: Wunderlich Securities Upgrades Ubiquiti Networks to Buy on Valuation
- Brean Murray Carret Reiterates Buy, $20 PT on Pitney Bowes on Cash Flow Confidence
- Financial Breakfast: Morning News Summary for May 31, 2012
- UPDATE: DA Davidson Raises PT to $45 on Texas Capital Bancshares on Higher Mortgage Revenues
- From Earlier: Velti Announces Purchase of Shares by Non-Executive Directors and Senior Employees
- Is Facebook Secretly Cloning the iPhone 5?
- David Einhorn's Greenlight Capital Letter to Investors Defends Apple, Doesn't Mention Herbalife
- Was IBM Smart to Ban Siri?
- James Altucher Article Sends Neonode Soaring
- Why Einhorn Is Wrong About Apple
- 5 Small-Cap Short Ideas
- Facebook and Apple Together at Last?
- Meat Glue Harbors Rogue Diseases, Government Fails to Intervene
- Stocks to Watch for the All Things Digital Conference: AAPL, ORCL, P, LNKD, ZNGA
- Social Media Chatter on Dell Around Its Earnings Report
